New emerging drugs in soft tissue sarcoma

Critical Reviews in Oncology/hematology
Amalia MilanoFrancesco Caponigro

Abstract

Doxorubicin and ifosfamide are the two most active drugs in the treatment of patients with advanced, soft tissue sarcoma (STS) of most histologic subtypes, aside from gastrointestinal stromal tumor (GIST). However, after failure of these drugs, alone or in combination, patients with advanced STS have few therapeutic options and the search for new active drugs is well worth pursuing. ET-743, a DNA minor groove binder, which blocks cell cycle progression in G2/M phase through a p53-independent apoptotic process, represents the most promising among novel compounds in STS, since recently completed phase II trials have consistently shown high survival, in spite of the relatively low incidence of major objective responses. The potential for combination with other active compounds further increases the appeal of ET-743. Imatinib mesylate is being tested also in STS other than GIST, which can overexpress one or more of the tyrosine kinases inhibited by imatinib; however, negative data have recently been presented. Clinical studies with a number of other compounds are ongoing or planned. However, investigators involved in the management of patients with advanced STS are to be increasingly aware of the emergence of new molecular targets ...Continue Reading

References

Jan 1, 1995·Cancer Chemotherapy and Pharmacology·C BlomqvistI Elomaa
Dec 1, 1996·American Journal of Clinical Oncology·J H EdmonsonJ B Gerstner
Dec 24, 1997·Anti-cancer Drugs·K M Skubitz
Oct 17, 1998·Cancer Investigation·E S CasperJ R Bertino
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P J WollJ Verweij
Feb 9, 2000·Cancer Chemotherapy and Pharmacology·O MerimskyM Inbar
Jul 27, 2000·Anti-cancer Drugs·E Späth-SchwalbeK Possinger
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E ErbaM D'Incalci
Mar 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L SvancárováO S Nielsen
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Aug 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian P RubinJames D Bruckner
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Robert G MakiCristina R Antonescu
Jan 17, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Allan T van OosteromUNKNOWN European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
May 15, 2003·Cancer Investigation·Keith M Skubitz
Sep 3, 2003·Nature Reviews. Cancer·Lee J Helman, Paul Meltzer
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A YovineJ L Misset
Apr 16, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Yui KitaokaHideo Honjo
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R Garcia-CarboneroG D Demetri
Jun 17, 2004·Seminars in Oncology·Blaine W RobinsonDonna S Shewach
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Louis GuillouJean-Michel Coindre
Nov 2, 2004·Obstetrics and Gynecology·Cathy Burke, Kevin Hickey
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grant A McArthurJonathan A Fletcher
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott OkunoCharles Erlichman
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R Garcia-CarboneroG D Demetri
Sep 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R D'AdamoRobert G Maki

❮ Previous
Next ❯

Citations

Jun 18, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sant P ChawlaErlinda M Gordon
Apr 14, 2010·Expert Opinion on Biological Therapy·Erlinda M Gordon, Frederick L Hall
Nov 19, 2008·Seminars in Diagnostic Pathology·José Luis OrdóñezEnrique de Alava
Oct 21, 2014·PloS One·Aliny Pereira LimaElisângela de Paula Silveira-Lacerda
May 18, 2017·Integrative Biology : Quantitative Biosciences From Nano to Macro·Manashjit GogoiRinti Banerjee
Mar 18, 2017·Physics in Medicine and Biology·Harley F RodriguesAndris F Bakuzis
Jun 7, 2008·Clinical Orthopaedics and Related Research·Akira KawaiSetsuo Hirohashi
Apr 24, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·François-Michel Le TourneauVincent Dubreuil
Jul 7, 2018·Beilstein Journal of Organic Chemistry·Sayantan BhaduriDev P Arya
Jun 17, 2008·The Oncologist·Scott M SchuetzeRenzo Canetta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis